{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Bayer CropScience Ltd
Bayer CropScience Ltd Technical Momentum Shifts Amid Bearish Signals
Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest day gain of 0.33%, the stock’s broader technical landscape reveals cautionary signals, underscoring challenges ahead for investors in the pesticides and agrochemicals sector.
Bayer CropScience Ltd is Rated Sell
Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with the latest insights into its performance and outlook.
Bayer CropScience Ltd is Rated Sell
Bayer CropScience Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 Oct 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 December 2025, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Bayer CropSci. Sees Revision in Market Evaluation Amidst Challenging Financial Trends
Bayer CropSci., a smallcap player in the Pesticides & Agrochemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued growth and valuation concerns, impacting investor sentiment and stock performance.
Bayer CropSci. Sees Revision in Market Evaluation Amid Challenging Financial Trends
Bayer CropSci., a small-cap player in the Pesticides & Agrochemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued growth and valuation concerns, prompting a reassessment of the company’s standing within its industry.
Why is Bayer CropSci. falling/rising?
As of 11-Nov, Bayer CropScience Ltd's stock price is Rs 4,506.85, down 2.83%, with a year-to-date return of -18.85%. The stock is underperforming its sector and the broader market, reflecting poor financial performance and negative growth indicators.
How has been the historical performance of Bayer CropSci.?
Bayer CropSci. has shown increasing net sales, reaching 5,473.40 Cr in March 2025, but experienced declines in operating profit, profit before tax, and profit after tax. Despite asset growth to 5,236.20 Cr, cash flow from operating activities significantly decreased, resulting in a net cash outflow of 271.00 Cr.
Are Bayer CropSci. latest results good or bad?
Bayer CropScience's latest Q2 FY26 results show strong revenue and profit growth, with net sales up 82.97% sequentially and net profit up 94.50%. However, declining operating margins and long-term profitability concerns suggest challenges ahead.
Bayer CropScience Q2 FY26: Strong Quarter Masks Underlying Margin Pressure
Bayer CropScience Ltd., a prominent player in India's pesticides and agrochemicals sector, reported a net profit of ₹278.70 crores for Q2 FY26 ended June 2025, marking a sequential surge of 94.50% from the preceding quarter's ₹143.30 crores. On a year-on-year basis, the company posted a 9.64% increase from ₹254.20 crores in Q2 FY25. Despite these headline gains, the stock has faced significant headwinds, plunging 30.80% over the past year and currently trading at ₹4,604.15 with a market capitalisation of ₹21,078 crores. The results reveal a company navigating seasonal volatility whilst grappling with margin compression that has persisted across multiple quarters.
Why is Bayer CropSci. falling/rising?
As of 06-Nov, Bayer CropScience Ltd's stock price is Rs 4,754.70, down 1.68% and has underperformed significantly with a year-to-date return of -14.39%. The stock is in a bearish trend, trading below moving averages, and has seen declining investor participation and poor long-term growth prospects.
Is Bayer CropSci. overvalued or undervalued?
As of October 17, 2025, Bayer CropScience is considered overvalued with a PE ratio of 38.24 and a year-to-date return of -9.24%, indicating it may not be a favorable investment compared to its peers and the Sensex.
Is Bayer CropSci. overvalued or undervalued?
As of October 17, 2025, Bayer CropSci. is considered overvalued with high valuation ratios and has underperformed against the Sensex, leading to a valuation grade change from very expensive to expensive.
Is Bayer CropSci. overvalued or undervalued?
As of October 17, 2025, Bayer CropScience is considered overvalued with a PE ratio of 38.24 and an expensive valuation grade, underperforming with a year-to-date return of -9.24% compared to the Sensex's 7.44%.
Is Bayer CropSci. technically bullish or bearish?
As of October 16, 2025, Bayer CropSci. exhibits a bearish trend with significant weakness, indicated by bearish MACD, moving averages, and KST across multiple time frames, despite a mildly bullish signal from Dow Theory.
Is Bayer CropSci. overvalued or undervalued?
As of October 16, 2025, Bayer CropSci. is considered very expensive and overvalued with a PE ratio of 38.93 and an EV to EBITDA of 30.61, underperforming with a year-to-date return of -7.58% compared to the Sensex's 6.82%.
Bayer CropScience Faces Bearish Technical Trends Amidst Market Challenges
Bayer CropScience has recently revised its evaluation amid challenging market conditions, with its stock showing a slight increase. Over the past year, the company has experienced a significant decline in stock return compared to the Sensex. Technical indicators suggest a bearish sentiment, reflecting ongoing competitive pressures.
How has been the historical performance of Bayer CropSci.?
Bayer CropSci has experienced consistent growth in net sales and total assets from Mar'19 to Mar'25, but profitability metrics have declined recently, with operating profit and net cash flow facing challenges.
Bayer CropScience Forms Death Cross, Signaling Potential Bearish Trend Ahead
Bayer CropScience has recently encountered a technical event known as a Death Cross, signaling potential downward momentum. The company, with a market capitalization of Rs 22,778.00 Cr, has seen a 24.30% decline over the past year, contrasting with the Sensex's positive performance. Current indicators suggest cautious monitoring is advisable.
Why is Bayer CropSci. falling/rising?
As of 24-Sep, Bayer CropScience Ltd's stock price is 5,035.05, down 0.71%, and has declined 5.9% over the last three days. Despite strong financial results and high management efficiency, the stock is underperforming its sector and trading below key moving averages, indicating a bearish trend.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
